Price
No data yet.
Social Signal Score
Revenue
$2.95M+257.63%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Richard Fang
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 75
- Beta
- -2.64
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 4.97
Financials
Revenue
$2.95M+257.6%Net Income
$-5.66MEBITDA
$-4.63MFree Cash Flow
$-1.35MEPS (diluted)
$-3.05Shares Outstanding (diluted)
1.86M+2414.3%Operating Expenses
$5.25MCash & Debt
$38.0KRevenue by Segment (annual)
$6.46MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.94M | $-27.00M | $-18.50 |
| 2024 | $4.39M | $-21.05M | $-16.50 |
| 2023 | $5.04M | $-15.57M | $-12.50 |
| 2022 | $4.11M | $-11.17M | $-9.00 |
Valuation
PMIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsglobenewswire.com·5h ago·Negative
…ses 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first and only total artificial heart approved by both the U.S. FDA and Health Canada, today reported financial results for the second quarter ended June 30, 2026.
View source ↗
Earnings
Typical surprise +5.7% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 19$-1.33 vs $-1.50beat
- Fri, May 15$-5.00 vs $-5.00beat
Estimates and results for PMI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by PMI officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.